Mostrar el registro sencillo del ítem

dc.contributor.authorPérez Ríos, Mónica*
dc.contributor.authorLópez-Medina, D.C.*
dc.contributor.authorGuerra-Tort, C.*
dc.contributor.authorRey-Brandariz, J.*
dc.contributor.authorVarela Lema, Leonor *
dc.contributor.authorSantiago Pérez, María Isolina*
dc.contributor.authorCandal, C.*
dc.contributor.authorMontes Martínez, Agustín*
dc.contributor.authorLópez, M.J.*
dc.contributor.authorDalmau, R.*
dc.contributor.authorProvencio, M.*
dc.contributor.authorFernández, E.*
dc.contributor.authorBlanco, A.*
dc.contributor.authorRuano Raviña, Alberto*
dc.date.accessioned2025-09-12T11:38:55Z
dc.date.available2025-09-12T11:38:55Z
dc.date.issued2023
dc.identifier.citationPérez-Ríos M, López-Medina DC, Guerra-Tort C, Rey-Brandariz J, Varela-Lema L, Santiago-Pérez MI, et al. Mortality Attributable to Environmental Tobacco Smoke Exposure in Spain in 2020. Archivos de Bronconeumologia. 2023;59(5):305-10.
dc.identifier.issn1579-2129
dc.identifier.otherhttps://portalcientifico.sergas.gal//documentos/642b3762a1c8a315fd23328f
dc.identifier.urihttp://hdl.handle.net/20.500.11940/21751
dc.description.abstractIntroduction and objectives: Exposure to environmental tobacco smoke (ETS) is associated with increased mortality and morbidity. The objective of this study was to estimate the impact of ETS exposure in Spain on mortality in 2020 in the population aged 35 years and over. Methods: A method of estimating attributable mortality (AM) based on the prevalence of ETS exposure was applied. Prevalence data were obtained from a representative study conducted in Spain and the relative risks were derived from a meta-analysis. AM point estimates are presented along with 95% confidence intervals (95% CI), calculated using a bootstrap naive procedure. AM, both overall and by smoking habit, was estimated for each combination of sex, age group, and cause of death (lung cancer and ischemic heart disease). A sensitivity analysis was performed. Results: A total of 747 (95% CI 676-825) deaths were attributable to ETS exposure, of which 279 (95% CI 256-306) were caused by lung cancer, and 468 (95% CI 417-523) by ischemic heart disease. Three-quarters (75.1%) of AM occurred in men and 60.9% in non-smokers. When chronic obstructive pulmonary disease and cerebrovascular disease are included, the burden of AM is estimated at 2242 deaths. Conclusions: ETS exposure is associated with 1.5% of all deaths from lung cancer and ischemic heart disease in the population aged 35 and over. These data underline the need for health authorities to focus on reducing exposure to ETS in all settings and environments.
dc.description.sponsorshipFunding Instituto de Salud Carlos III (ISCIII) , reference: PI22/00727, co-funded by the European Union.
dc.languageeng
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subject.meshMale *
dc.subject.meshHumans *
dc.subject.meshTobacco Smoke Pollution *
dc.subject.meshSpain *
dc.subject.meshSmoking *
dc.subject.meshMyocardial Ischemia *
dc.subject.meshLung Neoplasms *
dc.subject.meshEnvironmental Exposure *
dc.subject.meshRisk Factors *
dc.titleMortality Attributable to Environmental Tobacco Smoke Exposure in Spain in 2020
dc.typeArtigo
dc.authorsophosPérez-Ríos, M.; López-Medina, D.C.; Guerra-Tort, C.; Rey-Brandariz, J.; Varela-Lema, L.; Santiago-Pérez, M.I.; Candal, C.; Montes, A.; López, M.J.; Dalmau, R.; Provencio, M.; Fernández, E.; Blanco, A.; Ruano-Ravina, A.
dc.identifier.doi10.1016/j.arbres.2023.02.017
dc.identifier.sophos642b3762a1c8a315fd23328f
dc.issue.number5
dc.journal.titleArchivos de Bronconeumologia*
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS)
dc.organizationInstituto de Investigación Sanitaria de Santiago de Compostela (IDIS)
dc.organizationDirección Xeral de Saúde Pública
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS)
dc.organizationServizo Galego de Saúde::Áreas Sanitarias (A.S.) - Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS)
dc.page.initial305
dc.page.final310
dc.relation.projectIDInstituto de Salud Carlos III (ISCIII) [PI22/00727]
dc.relation.projectIDEuropean Union
dc.relation.publisherversionhttps://doi.org/10.1016/j.arbres.2023.02.017
dc.rights.accessRightsopenAccess*
dc.subject.keywordAS Santiago
dc.subject.keywordIDIS
dc.subject.keywordIDIS
dc.subject.keywordDXSP
dc.subject.keywordAS Santiago
dc.subject.keywordIDIS
dc.subject.keywordAS Santiago
dc.subject.keywordIDIS
dc.typefidesArtículo Científico (incluye Original, Original breve, Revisión Sistemática y Meta-análisis)
dc.typesophosArtículo Original
dc.volume.number59


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 International
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 International